Implantable or insertable medical devices containing radiation-crosslinked polymer for controlled delivery of a therapeutic agent

• US 20040202691A1
• Filed: 04/08/2003
• Published: 10/14/2004
• Est. Priority Date: 04/08/2003
• Status: Active Grant

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: Richard, Robert E.
• Granted Patent: US 7,241,455 B2
• Time in Patent Office: Days
• US Class Current: 424/423
• CPC Class Codes: A61K 9/0024 Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

An implantable or insertable medical device which comprises (a) a therapeutic agent and (b) a polymeric release region that controls the release of the therapeutic agent upon administration to a patient. The polymeric release region comprises a radiation-crosslinked polymer, and the polymeric release region is crosslinked with a radiation dose of at least 10,000 rads. The radiation-crosslinked polymer can be, for example, a radiation-crosslinked methylene-containing polymer. The polymeric release region can be, for example, (a) a carrier region that comprises the therapeutic agent or (b) a barrier region that is disposed over a therapeutic-agent-containing region that comprises the therapeutic agent. The present invention is further directed to methods of forming such medical devices, methods of releasing a therapeutic agent within a patient using such medical devices, and methods of modulating the release of a therapeutic agent from such medical devices.

Claims

1. An implantable or insertable medical device comprising (a) a therapeutic agent and (b) a polymeric release region that controls the release of said therapeutic agent upon administration to a patient, wherein said polymeric release region comprises a radiation-crosslinked polymer and wherein said polymeric release region is crosslinked with a radiation dose of at least 10,000 rads.

2. The implantable or insertable medical device of claim 1, wherein said radiation-crosslinked polymer is a radiation-crosslinked methylene-containing polymer.

3. The implantable or insertable medical device of claim 2, wherein said polymeric release region is crosslinked with a radiation dose of at least 100,000 rads.

4. The implantable or insertable medical device of claim 2, wherein said polymeric release region is crosslinked with a radiation dose of at least 1,000,000 rads.

5. The implantable or insertable medical device of claim 2, wherein said polymeric release region is a carrier region that comprises said therapeutic agent.

6. The implantable or insertable medical device of claim 2, wherein said polymeric release region is a barrier region disposed over a therapeutic-agent-containing region that comprises said therapeutic agent.

7. The implantable or insertable medical device of claim 2, wherein said polymeric release region is in the form of a coating layer.

8. The implantable or insertable medical device of claim 2, wherein said implantable or insertable medical device is selected from a catheter, a guide wire, a balloon, a filter, a stent, a stent graft, a vascular graft, a vascular patch, and a shunt.

9. The implantable or insertable medical device of claim 2, wherein said implantable or insertable medical device is adapted for implantation or insertion into the coronary vasculature, peripheral vascular system, esophagus, trachea, colon, biliary tract, urinary tract, prostate or brain.

10. The implantable or insertable medical device of claim 2, wherein said therapeutic agent is selected from one or more of the group consisting of an anti-thrombotic agent, an anti-proliferative agent, an anti-inflammatory agent, an anti-migratory agent, an agent affecting extracellular matrix production and organization, an antineoplastic agent, an anti-mitotic agent, an anesthetic agent, an anti-coagulant, a vascular cell growth promoter, a vascular cell growth inhibitor, a cholesterol-lowering agent, a vasodilating agent, and an agent that interferes with endogenous vasoactive mechanisms.

11. The implantable or insertable medical device of claim 2, wherein said polymeric release region has an elongation at break of at least 25% at ambient temperature.

12. The implantable or insertable medical device of claim 2, wherein said methylene-containing polymer has a glass transition temperature that is less than ambient temperature, before crosslinking.

13. The implantable or insertable medical device of claim 2, wherein said methylene-containing polymer comprises a plurality of (—

CH₂—

)_n backbone groups, where n=4 or greater.

14. The implantable or insertable medical device of claim 2, wherein said polymeric release region comprises a cyclic methylene-containing polymer.

15. The implantable or insertable medical device of claim 2, wherein said methylene-containing polymer further comprises a plurality of —

CH═

CH—

backbone groups.

16. The implantable or insertable medical device of claim 15, wherein said methylene-containing polymer is the reaction product of one or more 1,3-dienes.

17. The implantable or insertable medical device of claim 15, wherein said methylene-containing polymer is the product of an olefin metathesis reaction.

18. The implantable or insertable medical device of claim 17, wherein said methylene-containing polymer is the product of an acyclic diene metathesis polymerization reaction or a ring opening metathesis polymerization reaction.

19. The implantable or insertable medical device of claim 2, wherein said methylene-containing polymer is the product of a copolymerization reaction comprising (a) an acyclic unsaturated hydrocarbon monomer, and (b) an additional monomer.

20. The implantable or insertable medical device of claim 19, wherein said additional monomer is selected from acrylic monomers, aminoalkyl methacrylate monomers, vinyl ether monomers, cyclic ether monomers, unsaturated ester monomers, and halogenated unsaturated hydrocarbon monomers.

21. The implantable or insertable medical device of claim 19, wherein said acyclic unsaturated monomer is an alpha olefin.

22. The implantable or insertable medical device of claim 19, wherein said copolymer is selected from a random copolymer, a block copolymer, a graft copolymer and an alternating copolymer.

23. The implantable or insertable medical device of claim 19, wherein said acylic unsaturated monomer is ethylene and wherein said additional monomer is an alkyl acrylate.

24. The implantable or insertable medical device of claim 2, wherein said polymeric release region further comprises an additional polymer.

25. A method of forming the implantable or insertable medical device of claim 2, comprising:

(a) applying a coating comprising said methylene-containing polymer on a surface of an implantable or insertable medical device; and

(b) exposing said coating to a radiation dose of at least 10,000 rads.

26. The method of claim 25, wherein said radiation dose of at least 100,000 rads.

27. The method of claim 25, wherein said radiation dose of at least 1,000,000 rads.

28. The method of claim 25, wherein said radiation dose is provided by gamma ray or electron beam radiation.

29. The method of claim 25, wherein the rate of release of the therapeutic agent from the medical device is modulated by modifying the crosslinking radiation dose.

30. The method of claim 25, wherein said coating is applied over a therapeutic-agent-containing region that comprises said therapeutic agent.

31. A method of releasing a therapeutic agent within a patient comprising (a) providing the implantable or insertable medical device of claim 2 and (b) implanting or inserting the implantable or insertable medical device into a patient.

32. The method of claim 31, wherein said medical device is selected from a catheter, a guide wire, a balloon, a filter, a stent, a stent graft, a vascular graft, a vascular patch, and a shunt.

33. The method of claim 32, wherein said medical device is inserted into the vasculature.

34. The method of claim 33, wherein said therapeutic agent is released in the treatment of restenosis.

35. The method of claim 31, wherein the rate of release of the therapeutic agent from the medical device upon implantation or insertion of the device into a patient corresponds to a sustained release profile.